Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific Gains Approval Of Taxus Atom Stent For Small Vessels

This article was originally published in The Gray Sheet

Executive Summary

FDA approval for two Boston Scientific Taxus Express2 stents signals the firm is finally coming out from under the company-wide warning letter that has prevented it from launching new products, and suggests the agency will soon approve its next-generation Liberté paclitaxel-eluting stent
Advertisement

Related Content

Boston Scientific’s Taxus Liberté approved
Boston Scientific’s Taxus Liberté approved
Boston Scientific Plans 2008 Post-Warning Letter Interventional Launches
Boston Scientific Plans 2008 Post-Warning Letter Interventional Launches
Advertisement
UsernamePublicRestriction

Register

MT026605

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel